With over 30 years of distinguished experience in healthcare and life sciences, Mike Webb is a seasoned professional whose leadership has made a lasting impact on the industry. Recently, he held the positions of CEO and Board Member at Enveric Biosciences Inc., iQure Pharma Inc., GMDx, and CXL Ophthalmic, demonstrating his versatile expertise across diverse companies. Additionally, he served as a Board Member at DeuteRx.
Prior to joining the ESTERN Medical CRO Life Sciences Corporate & Scientific Advisory Board, Mike Webb made notable contributions to Ascent Therapeutics, a venture-backed company dedicated to developing pepducins, a groundbreaking platform for drug discovery. As the founder of Ascent, he played a pivotal role in shaping its trajectory. Before this venture, Mr. Webb served as the CEO of EPIX Pharmaceuticals, Inc. Under his leadership, EPIX evolved from a venture-backed startup to the global leader in pharmaceuticals for imaging with MRI & MRA. The company achieved worldwide approval for its lead product and successfully executed numerous public financings and corporate partnerships, including an IPO.
Before his tenure at EPIX, Mr. Webb held a senior position at CIBA, where he served as Senior Vice President, Worldwide Marketing and Strategic Planning of CIBA Diagnostics. In this role, he oversaw global marketing, program management, corporate planning, business development, and licensing. Prior to CIBA, he was a senior consultant at Booz, Allen & Hamilton, specializing in healthcare and life sciences.
Mike Webb’s educational background is impressive, with Bachelors degrees in Biochemistry and Economics from the University of Kansas, Summa Cum Laude. He continued his academic pursuits with an MA in International Relations from Sussex University in the UK, completing his thesis on “Pharmaceuticals Policy and the World Health Organization.” Additionally, he holds an MBA degree with honors from the Kellogg Graduate School of Management at Northwestern University.
Beyond his executive roles, Mr. Webb actively contributes to the industry as a board member of the Massachusetts Biotechnology Council, where he served as the past Chairman and the Kellogg Center for Biotechnology at Northwestern. He also serves as a Senior Advisor to Johnston and Blakely, a prominent life sciences investment banking firm. With a wealth of experience and a commitment to advancing the field, Mike Webb continues to be a respected figure in the healthcare and life sciences sector.
